DK372089A - Anvendelse af isoquinolinderivater - Google Patents

Anvendelse af isoquinolinderivater Download PDF

Info

Publication number
DK372089A
DK372089A DK372089A DK372089A DK372089A DK 372089 A DK372089 A DK 372089A DK 372089 A DK372089 A DK 372089A DK 372089 A DK372089 A DK 372089A DK 372089 A DK372089 A DK 372089A
Authority
DK
Denmark
Prior art keywords
isoquinoline derivatives
isoquinoline
derivatives
Prior art date
Application number
DK372089A
Other languages
English (en)
Other versions
DK372089D0 (da
Inventor
William Joseph Houlihan
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK372089D0 publication Critical patent/DK372089D0/da
Publication of DK372089A publication Critical patent/DK372089A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
DK372089A 1988-07-29 1989-07-27 Anvendelse af isoquinolinderivater DK372089A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22630588A 1988-07-29 1988-07-29
US07/302,720 US4910206A (en) 1986-07-14 1989-01-27 5-hetero-or aryl-substituted-imidazo(2,1-a)isoquinolines and their use as PAF receptor antagonists

Publications (2)

Publication Number Publication Date
DK372089D0 DK372089D0 (da) 1989-07-27
DK372089A true DK372089A (da) 1990-01-30

Family

ID=26920416

Family Applications (1)

Application Number Title Priority Date Filing Date
DK372089A DK372089A (da) 1988-07-29 1989-07-27 Anvendelse af isoquinolinderivater

Country Status (16)

Country Link
US (1) US4910206A (da)
EP (1) EP0357550B1 (da)
JP (1) JPH0273016A (da)
KR (1) KR910002445A (da)
AU (1) AU632487B2 (da)
CA (1) CA1336503C (da)
DE (1) DE68913397T2 (da)
DK (1) DK372089A (da)
ES (1) ES2062092T3 (da)
FI (1) FI893616L (da)
HU (1) HU206040B (da)
IE (1) IE63243B1 (da)
IL (1) IL91128A (da)
NO (1) NO177485C (da)
NZ (1) NZ230098A (da)
PT (1) PT91302B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0345931B1 (en) * 1988-04-27 1993-01-20 Schering Corporation Certain paf antagonist/antihistamine combinations and methods
US5530141A (en) * 1992-03-04 1996-06-25 Center For Innovative Technology 2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1,3-oxathiolanes; and 2,5-diaryl-1,3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5639782A (en) * 1992-03-04 1997-06-17 Center For Innovative Technology Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors
US5648486A (en) * 1992-07-13 1997-07-15 Cytomed, Inc. Compounds and methods for the treatment of inflammatory and immune disorders
US5463083A (en) 1992-07-13 1995-10-31 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5358938A (en) * 1992-07-13 1994-10-25 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
JPH08502243A (ja) 1992-07-13 1996-03-12 サイトメッド，インコーポレイテッド 炎症性および免疫性疾患の治療のための２，５‐ジアリールテトラヒドロ‐チオフェン、‐フランおよび類似体
US5434151A (en) * 1992-08-24 1995-07-18 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5703093A (en) * 1995-05-31 1997-12-30 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5750565A (en) 1995-05-25 1998-05-12 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5792776A (en) * 1994-06-27 1998-08-11 Cytomed, Inc., Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
FR2756560A1 (fr) * 1996-12-04 1998-06-05 Adir Nouveaux derives de l'imidazoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN1076728C (zh) * 1999-02-05 2001-12-26 浙江大学 2－芳基咪唑并[2,1－a]异喹啉的衍生物及其用途
WO2021057696A1 (zh) * 2019-09-27 2021-04-01 隆泰申医药科技(南京)有限公司 一种杂芳基类化合物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4101553A (en) * 1974-01-02 1978-07-18 Sandoz, Inc. Imidazo[2,1-a]isoquinolines
HU172649B (hu) * 1975-04-24 1978-11-28 Gyogyszerkutato Intezet Sposob poluchenija novykh biologicheski aktivnykh lizergamidov
EP0258175B1 (en) * 1986-07-14 1992-04-01 Sandoz Ag 5-hetero- or aryl-substituted-imidazo[2,1-a]isoquinolines

Also Published As

Publication number Publication date
ES2062092T3 (es) 1994-12-16
AU3901789A (en) 1990-02-01
FI893616A7 (fi) 1990-01-30
DE68913397T2 (de) 1994-08-11
IL91128A (en) 1996-01-31
IE63243B1 (en) 1995-04-05
KR910002445A (ko) 1991-02-25
IL91128A0 (en) 1990-03-19
DK372089D0 (da) 1989-07-27
HUT50630A (en) 1990-03-28
PT91302B (pt) 1995-03-01
CA1336503C (en) 1995-08-01
NZ230098A (en) 1992-02-25
NO177485C (no) 1995-09-27
IE892459L (en) 1990-01-29
DE68913397D1 (de) 1994-04-07
PT91302A (pt) 1990-02-08
JPH0273016A (ja) 1990-03-13
NO893062L (no) 1990-01-30
US4910206A (en) 1990-03-20
EP0357550A2 (en) 1990-03-07
AU632487B2 (en) 1993-01-07
EP0357550B1 (en) 1994-03-02
FI893616A0 (fi) 1989-07-28
NO893062D0 (no) 1989-07-27
FI893616L (fi) 1990-01-30
HU206040B (en) 1992-08-28
EP0357550A3 (en) 1991-04-03
NO177485B (no) 1995-06-19

Similar Documents

Publication Publication Date Title
FI915844A7 (fi) Uusia dihydro-isokinoliinijohdannaisia
DK55889D0 (da) Substituerede pyrroler
DK5789A (da) Isoquinolinderivater
DK344485A (da) Anvendelse af chromanderivater
DK84789D0 (da) Isoquinolinderivater
DK363887A (da) Anvendelse af bromcruptin
DK486686A (da) Anvendelse af benzamidderivater
DK372089D0 (da) Anvendelse af isoquinolinderivater
DK608888A (da) Anvendelse af polysaccharidderivater
DK273089D0 (da) Anvendelse af peptidderivater
DK120389A (da) Anvendelse af progestin
DK104389D0 (da) Anvendelse af imidazolderivater
DK104489D0 (da) Anvendelse af triazolderivater
DK87888D0 (da) Terapeutisk anvendelse af tindijoddeuteroporfyrin
DK316589D0 (da) Substituerede azacyclohexylderivater af rifamyciner
DK562289D0 (da) Anvendelse af somatostatiner
DK120689A (da) Komplekser af selen- og tellurderivater
DK326789D0 (da) Fremstilling af homonojirimycin-derivater
DK289887D0 (da) Anvendelse af avaron- og avarolderivater
DK289987A (da) Anvendelse af avaron- og avarolderivater
DK333587A (da) Anvendelse af pyridinderivater
DK689388D0 (da) Anvendelse af dihydropyridinderivater
DK0402857T3 (da) Anvendelse af 17beta-cyclopropylamino-androsten-derivater
IT8847653A0 (it) Sizzante comprendente 5 - idroscomposizione farmaceutica anoressitrpofano
DK118189D0 (da) Anvendelse af piperazinderivat

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment